13F reference period
Q2 2026
Security Snapshot
FRESENIUS MEDICAL CARE AG - Common Stock Institutional Ownership
CUSIP: D2734Z107
13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026
Institutions Reporting
1
Shares (Excl. Options)
9.1K
Full value: 9,100 · shares · 30 Jun 2026Price
$45.12
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 9,100
- Total 13F value
- $410,581
- Share change
- 0
- Number of holders
- 1
- Shares outstanding
- 268,958,280
- SEC-reported price per share
- $45.12
Latest holder snapshot
2 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- D2734Z107 - FRESENIUS MEDICAL CARE AG - Common Stock is tracked under CUSIP D2734Z107.
- 1 institution reported positions in Q2 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 1 to 1 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$408.99K
Full value: $408,987 · USD · 31 Mar 2026.$410.58K
Full value: $410,581 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 1 institution filings for Q2 2026.
Security key
D2734Z107
13F reference period
Q2 2026
13F holders
1
13D/G owners
1
CIK / CUSIP context first
Open Q2 2026 holders
D2734Z107 full holder history
Fresenius Medical Care AG SEC filings
Fresenius Medical Care AG company facts
Fresenius Medical Care AG insider transactions
Fresenius Medical Care AG 13D/G history
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP D2734Z107:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
D2734Z107
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 5% | 13,447,914 | BlackRock, Inc. | 30 Jun 2026 |
As of 30 Jun 2026,
1
institutional investors reported holding
shares of
FRESENIUS MEDICAL CARE AG - Common Stock.
This represents
0%
of the company’s total
outstanding shares.
9.1K
Full value: 9,100 · shares · 30 Jun 2026268.96M
Full value: 268,958,280 · shares · Stored outstanding share countQuarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
25
Headline period
Q2 2026
Rows shown
1-25 of 25
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 9,100 | $410,581 | $45.12 | 1 | |
| 2026 Q2 | 9,100 | $410,581 | $45.12 | 1 | |
| 2026 Q1 | 9,100 | $408,987 | $44.94 | 1 | |
| 2025 Q4 | 9,100 | $435,401 | $47.85 | 1 | |
| 2025 Q3 | 9,100 | $480,897 | -$809,016 | $52.85 | 1 |
| 2025 Q2 | 37,417 | $1,328,371 | +$809,016 | $42.82 | 2 |
| 2025 Q1 | 9,100 | $452,312 | +$452,312 | $49.70 | 1 |
| 2020 Q2 | 0 | $0 | -$27,000 | $45.12 | 0 |
| 2020 Q1 | 399 | $27,000 | +$27,000 | $67.67 | 1 |
| 2017 Q4 | 0 | $0 | -$33,000 | $45.12 | 0 |
| 2017 Q3 | 678 | $33,000 | $48.67 | 1 | |
| 2017 Q2 | 678 | $33,000 | $48.67 | 1 | |
| 2017 Q1 | 678 | $29,000 | $42.77 | 1 | |
| 2016 Q4 | 678 | $29,000 | +$29,000 | $42.77 | 1 |
| 2016 Q3 | 0 | $0 | -$821,000 | $45.12 | 0 |
| 2016 Q2 | 9,475 | $821,000 | $86.65 | 1 | |
| 2016 Q1 | 9,475 | $839,000 | $88.55 | 1 | |
| 2015 Q4 | 9,475 | $792,000 | +$792,000 | $83.59 | 1 |
| 2015 Q3 | 0 | $0 | -$782,000 | $45.12 | 0 |
| 2015 Q2 | 9,475 | $782,000 | $82.53 | 1 | |
| 2015 Q1 | 9,475 | $788,000 | +$788,000 | $83.17 | 1 |
| 2014 Q4 | 0 | $0 | -$662,000 | $45.12 | 0 |
| 2014 Q3 | 9,475 | $662,000 | $69.87 | 1 | |
| 2014 Q2 | 9,475 | $637,000 | $67.23 | 1 | |
| 2014 Q1 | 9,475 | $661,000 | +$661,000 | $69.76 | 1 |